Study Suggests Dapagliflozin May Prevent Acute Kidney Injury Post-Cardiac Surgery

A randomized clinical trial published in JAMA indicates that initiating dapagliflozin before elective cardiac surgery could help prevent acute kidney injury (AKI). This finding suggests a new therapeutic strategy to reduce AKI, a common and serious complication for patients undergoing these procedures, potentially improving patient outcomes.